Form D · Biotechnology

Proteus Industries Inc

Gloucester, MA · CIK 0001411115

Offering snapshot reported Apr 17, 2014 · SEC filing

Reported sold
$1.8M
Offering amount: $1.8M
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 16, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 17, 2014Initial$1,797,428No comparison21SEC filing
Jun 5, 2013Initial$1,798,500No comparison7SEC filing
Jun 30, 2009Initial$1,518,115No comparison17SEC filing
Nov 14, 2008Initial$100,000No comparisonNot reportedSEC filing
Aug 27, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-215816

Source: Form D, filed Apr 17, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Birmingham Director
Craig H. Deery Director
Timothy Driscoll Director
William G. Fielding Director
Michael Gorton Director
R. Douglas Hall Iii Director, Executive
R. Douglas Hall, Iii Director, Executive
Stephen Kelleher Director, Executive
James B. Maguire Director
James B. Maquire Director
Walter Suydam Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
33 Commercial Street
Gloucester, MA, 01930